---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-22-005227"
form_type: "8-K"
ticker: "UEEC"
cik: "0001096938"
company_name: "United Health Products, Inc."
filed_at: "2022-07-19T23:59:59+00:00"
generated_at: "2026-06-24T12:01:35.880714+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# UHP meets with FDA on PMA; manufacturing validation needed for review completion

## Summary
- On July 13, 2022, UHP and its consultant met with FDA team to discuss observations from initial PMA review.
- FDA indicated validation of certain manufacturing process elements is needed to complete PMA review.
- UHP to work expeditiously with manufacturing partner in coming weeks to accomplish remaining tasks.
- No assurance that PMA application will be approved.

## SEC filing metadata
- accession: 0001477932-22-005227
- form_type: 8-K
- ticker: UEEC
- cik: 0001096938
- company_name: United Health Products, Inc.
- filed_at: 2022-07-19T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1096938/000147793222005227/0001477932-22-005227-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1096938/000147793222005227/ueec_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-22-005227
- JSON: https://secwatch.observer/filing/0001477932-22-005227.json
- Plain text: https://secwatch.observer/filing/0001477932-22-005227.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.